Bedaquiline: how better to use it
Eur Respir J
.
2017 Nov 9;50(5):1701670.
doi: 10.1183/13993003.01670-2017.
Print 2017 Nov.
Authors
Jose A Caminero
1
2
,
Alberto Piubello
2
3
,
Anna Scardigli
4
,
Giovanni Battista Migliori
5
Affiliations
1
Pneumology Dept, Hospital General de Gran Canaria "Dr. Negrin", Las Palmas de GC, Spain.
2
Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
3
MDR-TB Division, Damien Foundation, Brussels, Belgium.
4
The Global Fund to Fight Aids, Tuberculosis and Malaria, Geneva, Switzerland.
5
Maugeri Care and Research Institute, IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.
PMID:
29122921
DOI:
10.1183/13993003.01670-2017
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents
Diarylquinolines*
Humans
Tuberculosis, Multidrug-Resistant*
Substances
Antitubercular Agents
Diarylquinolines
bedaquiline